Name	Quetiapine
Description	Quetiapine (ICI204636) is used for the therapy of schizophrenia, and for the treatment of acute manic episodes associated with bipolar I disorder. The mechanism of quetiapine' action is thought by mediated through antagonist activity at serotonin and dopamine receptors. Specifically, the D1 and D2 dopamine, the α1 adrenoreceptor and α2 adrenoreceptor, and 5-HT1A and 5-HT2 serotonin receptor subtypes are antagonized. Quetiapine also can inhibit the histamine H1 receptor.
Storage	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
Solubility Information	H2O : < 1 mg/mL (insoluble or slightly soluble) DMSO : 45 mg/mL (117.34 mM)
Keywords	Dopamine Receptor \| Quetiapine \| 5-HT2C \| 5-HT1A \| 5-hydroxytryptamine Receptor \| Antidepressant \| 5-HT Receptor \| ICI 204636 \| anxiolytic \| inhibit \| Inhibitor \| Serotonin Receptor \| ICI-204636 \| 5-HT2A
Inhibitors Related	Adiphenine hydrochloride \| Alverine citrate \| Dapoxetine hydrochloride \| Meclizine dihydrochloride \| Ribavirin \| Lidocaine \| Famotidine \| Octopamine hydrochloride \| Alginic acid
Related Compound Libraries	Bioactive Compound Library \| Pain-Related Compound Library \| Membrane Protein-targeted Compound Library \| Anti-Cancer Clinical Compound Library \| Drug Repurposing Compound Library \| Inhibitor Library \| Anti-Cancer Approved Drug Library \| FDA-Approved Drug Library \| Bioactive Compounds Library Max \| Anti-Cancer Drug Library

Quetiapine NEW

Product Introduction